Bracco Diagnostics CardioGen-82 Infusion System - HSA Registration DE0510451
Access comprehensive regulatory information for Bracco Diagnostics CardioGen-82 Infusion System in the Singapore medical device market through Pure Global AI's free database. This CLASS C medical device is registered under HSA registration number DE0510451 and owned by Bracco Diagnostics Inc.. The device was registered on March 12, 2025.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The CardioGen-82ยฎ Infusion System is intended to be used with the Cardiogen-82ยฎ Generator to deliver the radiopharmaceutical eluate rubidium (Rb 82) chloride injection to a patient in a controlled manner. Users of the CardioGen-82ยฎ Infusion System must be Nuclear Medicine Technologists. The CardioGen-82ยฎ Infusion System is intended to be used in a healthcare facility.

